Curi RMB Capital LLC Cuts Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Curi RMB Capital LLC lessened its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 91.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,650 shares of the company's stock after selling 51,150 shares during the period. Curi RMB Capital LLC's holdings in Henry Schein were worth $339,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in Henry Schein by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company's stock valued at $1,165,425,000 after purchasing an additional 260,537 shares during the period. American Century Companies Inc. grew its stake in Henry Schein by 3.1% during the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company's stock worth $351,543,000 after buying an additional 162,477 shares in the last quarter. Swedbank AB acquired a new stake in Henry Schein in the first quarter valued at approximately $215,998,000. Nuance Investments LLC raised its stake in Henry Schein by 6.2% during the second quarter. Nuance Investments LLC now owns 1,863,333 shares of the company's stock worth $119,440,000 after buying an additional 108,143 shares during the last quarter. Finally, Burgundy Asset Management Ltd. raised its stake in Henry Schein by 1.0% during the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company's stock worth $105,148,000 after buying an additional 16,476 shares during the period. Institutional investors own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HSIC. Baird R W raised Henry Schein from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 22nd. Robert W. Baird lowered their target price on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 7th. Evercore ISI boosted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. UBS Group reduced their target price on Henry Schein from $75.00 to $72.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 7th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $78.89.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business's stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Stock Up 3.3 %

NASDAQ:HSIC traded up $2.22 during trading hours on Friday, reaching $68.76. 2,510,286 shares of the company traded hands, compared to its average volume of 1,499,429. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63. The stock has a market capitalization of $8.57 billion, a P/E ratio of 28.30, a P/E/G ratio of 1.97 and a beta of 0.87. The business's 50-day moving average price is $70.30 and its two-hundred day moving average price is $69.57. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter in the prior year, the business earned $1.32 EPS. The business's quarterly revenue was up .4% on a year-over-year basis. Analysts predict that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.